Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,061,833
-
Share change
-
+30,153
-
Total reported value
-
$175,993,013
-
Price per share
-
$43.33
-
Number of holders
-
86
-
Value change
-
+$973,668
-
Number of buys
-
40
-
Number of sells
-
44
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q4 2017
As of 31 Dec 2017,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,061,833 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Stonepine Capital Management, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, Elk Creek Partners, LLC, RICE HALL JAMES & ASSOCIATES, LLC, AQR CAPITAL MANAGEMENT LLC, EAGLE ASSET MANAGEMENT INC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.